Process inefficiencies in an oncology center are not inevitable. They’re just extremely common. With the right combination of data analysis and management strategies, your hospital could remove backlogs, improve clinical trial matching, and enhance daily operations. That’s why we’re excited to announce our upcoming webinar, ‘Critical Missteps in Oncology Management: How Hospitals Are Falling Short in Cancer Care and Research’, where we explore how your oncology department can leverage such strategies to drive operational efficiency, improve financial stability and deliver better care to every patient. We are joined by 3 industry innovators - Dinesh Pal Mudaranthkam, Ph.D., Ulysses G. J. Balis, MD, FCAP, FASCP, Fellow AIMBE, and Timothy Masters R.T.(R)(ARRT), CIIP – each with their own first-hand experience of turning oncology departments into recognized centers of excellence. ⏰ Join us on March 21st at 4 pm EDT. Secure your space by clicking the link below 👇 https://hubs.li/Q02nKZRG0

Mark your calendars now for this relevant and interesting webinar!

📣Parexel weighs in on the FDA's new Oncology Guidance. 📣   Mwango Kashoki MD MPH, SVP and Global Head of Regulatory Strategy, recently wrapped up a compelling interview series with Andy Studna of Applied Clinical Trials Magazine. Here’s a quick recap:   🎥 1. Initial Reactions: Thoughts on the FDA's latest guidance on multiregional clinical trials in oncology and its potential to transform the landscape. https://lnkd.in/eyEh6rfb 🌍 2. Driving Diversity: How by promoting more diverse trial site locations and patient populations, there’s potential for more inclusive oncology studies. https://lnkd.in/e7yQSiTU 📅 3. Planning Ahead: Why sponsors will need to be even more strategic in planning their oncology trials to align with the new guidelines. https://lnkd.in/ek3xzckS ⚖️ 4. Regulatory Challenges: On the complexities of meeting multiple regulatory requirements across different regions. https://lnkd.in/eHg927yd 🔍 5. Better Trials Ahead: How this guidance could lead to better design in oncology trials and ultimately greater diversity in patient representation. https://lnkd.in/eMm-uym8 What are your thoughts on the new guidance? Share in the comments below!  #ClinicalTrials #Oncology #DiversityInTrials #FDAGuidance #Regulatory

The survival of independent oncology practices hinges on maximizing every revenue opportunity. Yet many practices continue to trust their complex billing to generic medical billing companies that lack specialized oncology expertise. At Oncology Convergence, we deliver collection rates as high as 99.8% because we understand that oncology billing isn't just about processing claims – it's about: Mastering complex drug billing and inventory management Navigating intricate clinical trial documentation Executing precise specialty pharmacy coordination Managing complex prior authorization requirements Understanding payer-specific oncology protocols When your practice represents not just a business, but a lifeline for your community's cancer patients, you can't afford to compromise on billing expertise. Ready to see the difference specialized oncology billing can make? Let's talk. #OncologyBilling #PracticeManagement #HealthcareLeadership #Revenue #MedicalBilling #Oncology

Planning & optimizing oncology trials is challenging in this increasingly complex, fast-paced environment. Knowing and understanding adaptive trial designs and master protocols is critical to accelerating clinical research. Watch this webinar to discover efficient clinical trial design strategies & how leveraging technology is necessary for navigating today’s complex environment. Key Take-Aways -Industry insights into clinical oncology research -Understanding adaptive trial designs in oncology (platform, basket, and umbrella) -What to consider and when to act when planning complex clinical trials -How to leverage advanced eClinical technology for multi-faceted protocols Download here: http://ow.ly/7FW150NmWUA

Navigating the complex oncology landscape of market access? Envision - your strategic compass for recently approved oncology assets.     Our forward-looking evaluations provide invaluable insights months ahead of formal HTA decisions, bridging the gap between regulatory approval and market viability. Make informed decisions with major downstream implications for your product's success.    Watch our interview with Executive Director Tijana Ignjatovic as she discusses how with Envision you can access forward-looking evaluations and comprehensive strategic direction for market access viability after a product has received positive EMA or FDA guidance.   #MarketAccess #Oncology #StrategicPlanning 

Ever wonder if your oncology program is achieving all that it can? Check out our 5-step oncology positioning tool to see if there are any stones left unturned that could lead to greater success.

Look around 👀 You likely see some people talking about interesting things they want to do in their careers and others who are actually doing interesting things The difference? Some people take action and others don’t. Have you noticed that time seems to move faster as you get older? It’s freakishly easy to let a few, or even many, years slip by without doing the things you say you want to do. This is the trap of becoming comfortable. You find a rhythm that works and you lean into it more and more until you’re in so deep it takes a gigantic effort to swim out. Stop letting time slip by you like there is an endless supply of it - there are no “perfect” moments, there is only right now --- 📌 When you’re ready to build your oncology knowledge like you say you want to, I can help you. Start by getting the Oncology Insights Newsletter that fosters your continuous growth in oncology pharmacy practice https://lnkd.in/gYyirSen I’m the Kelley in KelleyCPharmD 👋 and I help pharmacists learn the complex world of oncology #LearnOncology #Pharmacists #OncologyPharmacists #Oncology

🔬🩺 Dive into Oncology Insights with MHN's Oncologist Physician Panel! 🌟 Calling all pharmaceutical companies and market research firms! Are you seeking in-depth insights into the world of oncology? You can look no further than MHN's exclusive panel of oncology specialist physicians. Plan your project here: https://lnkd.in/er-_cxKu In the ever-evolving landscape of cancer treatment and research, understanding the perspectives of oncology specialists is paramount. With MHN's panel, gain access to diverse expertise and perspectives that can enrich your research initiatives. From evaluating new treatment options 👀 to understanding patient care challenges, our oncology specialist panel offers unparalleled insights that can shape your strategies and drive meaningful impact in the fight against cancer. Partner with us to unlock a wealth of oncology insights and propel your pharmaceutical endeavors to new heights. With MHN by your side, you'll navigate the complexities of oncology research with confidence and precision. Reach out to us today to embark on a journey towards transformative insights and impactful solutions! #OncologyInsights #SpecialistPhysicians #CancerResearch 🧬 #RepresentativeSamples #MarketResearch 🚀🔍 #QualitativeResearch 🍎 #QuantitativeResearch #MHN #MHNInsights

⌛️ Final chance to join our webinar on oncology management missteps. From unoptimized processes to underutilized registry data, most oncology departments are not achieving their potential. But with a few important operational changes, they could improve their patient care, reputation and organizational revenue. Our webinar will teach you exactly what those changes are - with the help of 3 esteemed industry innovators, all with experience using technology to transform oncology processes. But you’ll need to act fast: there are limited spaces left! Click the link below to check for available spaces. https://hubs.li/Q02nL33w0